Personalized allele-specific antisense oligonucleotides for GNAO1-neurodevelopmental disorder
GNAO1-associated disorders are ultra-rare autosomal dominant conditions, which can manifest, depending on the exact pathogenic variant in GNAO1, as a spectrum of neurological phenotypes, including epileptic encephalopathy, developmental delay with movement disorders, or late-onset dystonia. There ar...
Saved in:
Main Authors: | Inna Shomer, Nofar Mor, Shaul Raviv, Noga Budick-Harmelin, Tanya Matchevich, Sharon Avkin-Nachum, Yoach Rais, Rebecca Haffner-Krausz, Ariela Haimovich, Aviv Ziv, Reut Fluss, Bruria Ben-Ze’ev, Gali Heimer, Denis N. Silachev, Vladimir L. Katanaev, Dan Dominissini |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253124003196 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vivo efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidney
by: Toshiki Tsuboi, et al.
Published: (2025-03-01) -
RNA structure in alternative splicing regulation: from mechanism to therapy
by: Bao Nengcheng, et al.
Published: (2024-07-01) -
Pathogenetic therapeutic approaches for endocrine diseases based on antisense oligonucleotides and RNA-interference
by: Olga Golounina, et al.
Published: (2025-01-01) -
Beyond the usual challenges, a case of LV summit PVCs ablation in child with ASO for D-TGA
by: Mahmoud Abdelfattah, et al.
Published: (2024-12-01) -
Targeting RNA splicing modulation: new perspectives for anticancer strategy?
by: Xuemei Lv, et al.
Published: (2025-01-01)